DOSSIER · 13F Holders · Q2 2026
XERS 8 07/15/28
XERIS BIOPHARMA HOLDINGS INC
3 institutions still hold XERIS BIOPHARMA HOLDINGS INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 98422EAB9·3 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
3 institutions reported XERS 8 07/15/28 in Q2 2026. CAPSTONE INVESTMENT ADVISORS, LLC leads at 68.5% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.